Elsevier

Biomaterials

Volume 198, April 2019, Pages 204-216
Biomaterials

Multiscale bioprinting of vascularized models

https://doi.org/10.1016/j.biomaterials.2018.08.006Get rights and content

Abstract

A basic prerequisite for the survival and function of three-dimensional (3D) engineered tissue constructs is the establishment of blood vessels. 3D bioprinting of vascular networks with hierarchical structures that resemble in vivo structures has allowed blood circulation within thick tissue constructs to accelerate vascularization and enhance tissue regeneration. Successful rapid vascularization of tissue constructs requires synergy between fabrication of perfusable channels and functional bioinks that induce angiogenesis and capillary formation within constructs. Combinations of 3D bioprinting techniques and four-dimensional (4D) printing concepts through patterning proangiogenic factors may offer novel solutions for implantation of thick constructs. In this review, we cover current bioprinting techniques for vascularized tissue constructs with vasculatures ranging from capillaries to large blood vessels and discuss how to implement these approaches for patterning proangiogenic factors to maintain long-term, stimuli-controlled formation of new capillaries.

Introduction

The engineered tissue constructs consist of self-assembled cell aggregates, synthetic materials, biological scaffolds, or porous hydrogels and fibrous meshes with macroscale characteristics that promote cell adhesion, migration, and proliferation [1]. The balance of migration and proliferation of encapsulated cells over their life cycles requires consistent delivery of nutrients and oxygen [2], in particular when constructs implanted for ischemic heart disease [3] and diabetic ulcers [4]. It is thus important to create functional blood vessel networks ranging from a few micrometers to millimeters within complex structures, such as liver, kidney, and heart [5,6] (Fig. 1). Vascular systems in vivo include a mixture of different cell types that undergo continuous remodeling by stimuli from endothelial, nervous, immune, and endocrine cells [7]. They also play a key role in graft perfusion and integration of implants into the host vascular system [8,9]. Vascular growth is further associated with developmental processes of angiogenesis, wound healing, and the progression of various pathologies such as cancer [9,10]. Despite significant improvements of current technologies to create three-dimensional (3D) blood vessels, the formation of a functional engineered vascular system with multiscale vessel networks from capillaries to large vessels has remained challenging in this field [11]. Inability in fabrication of 3D vascular networks has limited tissue engineering in the growth of thick tissue or organ-level constructs.

Many approaches have been proposed to induce the growth of a vascular system within 3D engineered tissue constructs [12]. Vascularization has been induced within tissue constructs by incorporation of growth factors into the construct [12] (which yields vasculogenesis), seeding endothelial cells in the construct to stimulate angiogenesis [13], or engineering multiscale microfluidic channels inside biocompatible materials using various microfabrication technologies [14]. Either naturally- or synthetically-derived scaffolds when mixed with proangiogenic factors yield de novo formation of capillaries [15]. In another strategy, co-cultures of endothelial cells and other cell types of the desired organ were used within tissue scaffolds prior to their implantation [16]. This strategy depends on the biological properties of endothelial cells to promote the formation of neo-capillaries in vivo. Such process can be described by remodeling phenomenon driven by the endothelial cells that are activated by the proangiogenic agents [17]. For example, in the case of human umbilical vein endothelial cell (HUVEC)-loaded collagen hydrogel implant, a tree-like structure of branched capillaries was observed over two months of implantation [17]. Several other studies have shown the ability of endothelial cells along with mesenchymal stem cells (MSCs) to form a stable vascular system under both in vitro and in vivo conditions [18,19]. In addition to these strategies, microfabrication techniques have been developed to generate perfusable channels in hydrogels [[20], [21], [22]]. Similarly, pre-implant fabrication of capillary networks into tissues constructs has shown accelerated implant integration into the host tissue as well as the formation of capillary-like structures coupled with the host vasculature [23,24]. However, these approaches lack the ability to directly generate multiscale vessel networks along with anastomosis in the host tissue, which is one of the major challenges in tissue integration.

Conventional engineering of vascular tubes includes sheet rolling and tubular molding [25]. In sheet rolling, a sheet of cellular or acellular biomaterials is rolled over a predefined mandrel and it remodels to a stable and homogeneous structure [26]. The tubular molding can also be used to shape injected biomaterials and crosslink or solidify the tube inside the annular mold [27]. These fabrication methods lack proper control on the structure and are limited to mesoscale blood vessel size (Fig. 1). Recent advancements in materials engineering and microfabrication techniques have further led to the development of new strategies [11] that offer precise control over various aspects of the cell-laden tissue implants including cell patterning [28], cell phenotype [29], cellular alignment [30], as well as the microenvironmental cues including mechanical properties [6], chemical properties (e.g. ligand density), and topographic features (e.g. cell adhesiveness) [9]. Such manipulations along with the use of 3D bioprinting techniques have been successfully applied to overcome the technical challenges of fabricating a functional microvasculature (as shown in Fig. 1 and summarized in Table 1) [6]. Bioprinting has become an essential tool for fabricating vascularized tissue constructs, in which the design of printable, tunable and biocompatible bioinks is essential [9,31]. Common examples of bioinks with proper biophysical properties and endogenous cellular cues are alginate [31,32] and gelatin methacryloyl (GelMA) hydrogels [[33], [34], [35], [36]]. In addition, the integration of time into bioprinting process known as four-dimensional (4D) bioprinting yields variations in configurational and/or biophysical characteristics of tissue constructs in response to environmental stimuli, which lead to a more realistic formation of capillaries [37]. In this review, we summarize recent 3D bioprinting techniques including sacrificial, core/shell bioprinting techniques and innovations in bioprinting approaches such as 4D bioprinting for making vascularized tissue constructs [9,11]. We then discuss how nanotechnology can be integrated into the fabrication process to advance delivery of proangiogenic factors and therapeutic compounds. Temporal controls over distributions of neo-capillaries within pre-vascularized implants may solve existing challenges in cell encapsulation of thick tissue constructs, while the designed vasculature can help anastomosis after implantation. Such vascularized models can be designed to deliver therapeutic molecules into the body circulation in a controlled fashion.

Section snippets

Sacrificial bioprinting

Classical bioprinting techniques include active printing of cellular and extracellular components in a predefined shape. Such approaches require rapid gelation or crosslinking process to provide a stable hollow tube construct [9,38]. To overcome challenges associated with printability of hydrogels and the lack of structural support in fabricating hollow tube constructs, researchers print sacrificial channels that are supported by surrounding walls and then dissolve the channels, known as

Alginate-based bioprinting

Among various bioprinting strategies, core/shell geometry seems efficient and promising in creating vascular networks (Fig. 4 A, B) [67]. The main benefit of the core/shell structure is the capacity of fabricating hierarchical, multi-layer tissue constructs with desirable biological and mechanical properties [67]. As a low-cost material, numerous bioengineers employ alginate hydrogel as a component in the design and fabrication of bioinks. Alginate is a naturally occurring, nontoxic,

Biomaterials in 4D bioprinting

The dynamic environment of hydrogel scaffolds can be designed with chemical or physical functionalities to control time dimension. 4D bioprinting has been introduced in tissue engineering due to its intrinsic features such as (i) biofabrication of 3D scaffolds with programmable architectures using stimuli-responsive materials capable of changing their shape and function in response to external stimuli, and (ii) post-maturation of printed cells within scaffolds, generating complex tissue

Concluding remark and future directions

The classical strategy to create multiscale capillaries is to fabricate a large endothelialized vascular channel within the construct and tune the surrounding microstructure to induce capillary formation from the channel. These models lack directionality of vessel formation and cannot resemble the native vessels. We have reviewed current bioprinting techniques for fabricating vascularized models (see also Table 1). The use of sacrificial strategy with extrusion bioprinting has been employed by

Acknowledgements

The authors acknowledge funding from the National Institutes of Health (EB021857, AR066193, AR057837, CA214411, HL137193, EB024403, EB023052, EB022403), and Air Force Office of Sponsored Research under award # FA9550-15-1-0273. A.K.M. acknowledges the fellowships from the Fonds de Recherche du Québec–Santé (FRQS) and Canadian Institutes of Health Research (CIHR). S.M. acknowledges the American Fund for Alternatives to Animal Research for AFAAR Postdoctoral Fellowship. S.R.S. would like to thank

References (133)

  • R.E. Saunders et al.

    Delivery of human fibroblast cells by piezoelectric drop-on-demand inkjet printing

    Biomaterials

    (2008)
  • X. Cui et al.

    Human microvasculature fabrication using thermal inkjet printing technology

    Biomaterials

    (2009)
  • T. Xu et al.

    Inkjet printing of viable mammalian cells

    Biomaterials

    (2005)
  • F. Guillemot et al.

    High-throughput laser printing of cells and biomaterials for tissue engineering

    Acta Biomater.

    (2010)
  • B. Guillotin et al.

    Laser assisted bioprinting of engineered tissue with high cell density and microscale organization

    Biomaterials

    (2010)
  • K.Y. Lee et al.

    Alginate: properties and biomedical applications

    Prog. Polym. Sci.

    (2012)
  • Q. Gao et al.

    Coaxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery

    Biomaterials

    (2015)
  • W. Jia et al.

    Direct 3D bioprinting of perfusable vascular constructs using a blend bioink

    Biomaterials

    (2016)
  • C. Norotte et al.

    Scaffold-free vascular tissue engineering using bioprinting

    Biomaterials

    (2009)
  • S. Hong et al.

    Cellular behavior in micropatterned hydrogels by bioprinting system depended on the cell types and cellular interaction

    J. Biosci. Bioeng.

    (2013)
  • B. Gao et al.

    4D bioprinting for biomedical applications

    Trends Biotechnol.

    (2016)
  • M.W. Laschke et al.

    Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes

    Tissue Eng.

    (2006)
  • H. Bae et al.

    Building vascular networks

    Sci. Transl. Med.

    (2012)
  • S. Fukuda et al.

    Angiogenic strategy for human ischemic heart disease: brief overview

    Mol. Cell. Biochem.

    (2004)
  • S. Bennett et al.

    Growth factors in the treatment of diabetic foot ulcers

    Br. J. Surg.

    (2003)
  • T. Kaully et al.

    Vascularization—the conduit to viable engineered tissues

    Tissue Eng. B Rev.

    (2009)
  • D.B. Kolesky et al.

    Three-dimensional bioprinting of thick vascularized tissues

    Proc. Natl. Acad. Sci. Unit. States Am.

    (2016)
  • A. Atala et al.

    Engineering complex tissues

    Sci. Transl. Med.

    (2012)
  • M.D. Guillemette et al.

    Tissue-engineered vascular adventitia with vasa vasorum improves graft integration and vascularization through inosculation

    Tissue Eng.

    (2010)
  • D. Richards et al.

    3D bioprinting for vascularized tissue fabrication

    Ann. Biomed. Eng.

    (2017)
  • S.J. Paulsen et al.

    Tissue vascularization through 3D printing: will technology bring us flow?

    Dev. Dynam.

    (2015)
  • M. Ehrbar et al.

    Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth

    Circ. Res.

    (2004)
  • L. Martineau et al.

    Angiogenic response of endothelial cells seeded dispersed versus on beads in fibrin gels

    Angiogenesis

    (2007)
  • J.T. Borenstein et al.

    Microfabrication technology for vascularized tissue engineering

    Biomed. Microdevices

    (2002)
  • N. Koike et al.

    Tissue engineering: creation of long-lasting blood vessels

    Nature

    (2004)
  • J.M. Sorrell et al.

    Influence of adult mesenchymal stem cells on in vitro vascular formation

    Tissue Eng.

    (2009)
  • M.C. Ford et al.

    A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks invivo

    Proc. Natl. Acad. Sci. U. S. A.

    (2006)
  • J. Liu et al.

    Hydrogels for engineering of perfusable vascular networks

    Int. J. Mol. Sci.

    (2015)
  • A. Hasan et al.

    A multilayered microfluidic blood vessel-like structure

    Biomed. Microdevices

    (2015)
  • Y. Ling et al.

    A cell-laden microfluidic hydrogel

    Lab a Chip

    (2007)
  • M.E. Francis et al.

    Endothelial cell–matrix interactions in neovascularization

    Tissue Eng. B Rev.

    (2008)
  • M. Clauss et al.

    Mechanisms of Angiogenesis

    (2004)
  • S. Amensag et al.

    Rolling the human amnion to engineer laminated vascular tissues

    Tissue Eng. C Meth.

    (2012)
  • B. Tschoeke et al.

    Development of a composite degradable/nondegradable tissue-engineered vascular graft

    Artif. Organs

    (2008)
  • X. Cui et al.

    Thermal inkjet printing in tissue engineering and regenerative medicine

    Recent Pat. Drug Deliv. Formulation

    (2012)
  • R. Bhuthalingam et al.

    A novel 3D printing method for cell alignment and differentiation

    Int. J. Bioprint.

    (2015)
  • S. Khalil et al.

    Bioprinting endothelial cells with alginate for 3D tissue constructs

    J. Biomech. Eng.

    (2009)
  • L.E. Bertassoni et al.

    Direct-write bioprinting of cell-laden methacrylated gelatin hydrogels

    Biofabrication

    (2014)
  • D.B. Kolesky et al.

    3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs

    Adv. Mater.

    (2014)
  • L.E. Bertassoni et al.

    Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs

    Lab a Chip

    (2014)
  • Cited by (177)

    View all citing articles on Scopus
    1

    Equal contributions.

    View full text